Because Ned Said: As the Election Looms, Will Drug Price Negotiations Sway Voters?

In his latest article for Pharmacy Times, Ned Milenkovich, chair of Much’s Health Care group, examined whether or not Medicare’s new authority to negotiate prescription drug prices under the Inflation Reduction Act could become an issue for voters in the upcoming election. He explains that while the policy promises lower out-of-pocket costs for senior citizens, the long-term implications for the pharmacy industry remains uncertain.